Venture funding, dealmaking slowed in biotech last year: Pitchbook

Venture funding, dealmaking slowed in biotech last year: Pitchbook

    11 Jan 2024

Dive Brief: The number and amount of biotechnology financings dipped in 2023, with venture...

5 questions facing pharma in 2024

5 questions facing pharma in 2024

    11 Jan 2024

The arrival of powerful new drugs for obesity has reshaped the pharmaceutical industry, transforming...

GSK to buy asthma drug startup Aiolos for $1B

GSK to buy asthma drug startup Aiolos for $1B

    10 Jan 2024

Over the span of five months, biotechnology startup Aiolos Bio launched, raised initial funding...

JPM24: Pfizer’s tough sell, the next Karuna and building a biotech platform

JPM24: Pfizer’s tough sell, the next Karuna and building a biotech platform

    10 Jan 2024

Biotechnology’s embrace of artificial intelligence was never more literal than Tuesday at the J.P....

FDA authorizes Florida to import drugs from Canada

FDA authorizes Florida to import drugs from Canada

    06 Jan 2024

For the first time, the Food and Drug Administration has authorized a U.S. state...

An unusual drugmaker raises north of $100M for ecstasy-based PTSD therapy

An unusual drugmaker raises north of $100M for ecstasy-based PTSD therapy

    06 Jan 2024

A California-based company has raised tens of millions of dollars to support its mission...

Intellia to lay off staff, cut some early research

Intellia to lay off staff, cut some early research

    05 Jan 2024

CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of...

Lilly launches online service for home delivery of weight loss drug

Lilly launches online service for home delivery of weight loss drug

    04 Jan 2024

Dive Brief: Eli Lilly wants to make it easier for people to access its...

Pfizer wins Canadian OK for hemophilia treatment, its first gene therapy

Pfizer wins Canadian OK for hemophilia treatment, its first gene therapy

    04 Jan 2024

Dive Brief: Canada’s health regulators have approved Pfizer’s gene therapy for hemophilia B, the...

FDA ends busy year with three drug rejections

FDA ends busy year with three drug rejections

    03 Jan 2024

The Food and Drug Administration closed out 2023 with rejections of three drugmaker applications...